Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Parkin

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 21, 2001
The early bactericidal activity of amikacin in pulmonary tuberculosisP R Donald, F A Sirgel, A Venter, et al.
American Journal of Respiratory and Critical Care Medicine|October 6, 1997
The early bactericidal activity of ciprofloxacin in patients with pulmonary tuberculosisF A Sirgel, F J Botha, D P Parkin, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1993
The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts: a new method of drug assessmentF A Sirgel, F J Botha, D P Parkin, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 2, 2002
The early bactericidal activity of streptomycinP R Donald, F A Sirgel, A Venter, et al.
Archives of Disease in Childhood|May 24, 2005
Isoniazid pharmacokinetics in children treated for respiratory tuberculosisH S Schaaf, D P Parkin, H I Seifart, et al.
Expert Review of Anti-Infective Therapy|October 16, 2004
Early bactericidal activity of antituberculosis agentsP R Donald, F A Sirgel, A Venter, et al.
Scandinavian Journal of Infectious Diseases|July 14, 2001
Early bactericidal activity of amoxicillin in combination with clavulanic acid in patients with sputum smear-positive pulmonary tuberculosisP R Donald, F A Sirgel, A Venter, et al.
European Journal of Clinical Pharmacology|May 17, 2007
The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazidP R Donald, D P Parkin, H I Seifart, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2004
The influence of human N-acetyltransferase genotype on the early bactericidal activity of isoniazidP R Donald, F A Sirgel, A Venter, et al.
American Journal of Respiratory and Critical Care Medicine|October 6, 1997
The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosisP R Donald, F A Sirgel, F J Botha, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 21, 2001
The early bactericidal activity of amikacin in pulmonary tuberculosisP R Donald, F A Sirgel, A Venter, et al.
American Journal of Respiratory and Critical Care Medicine|October 6, 1997
The early bactericidal activity of ciprofloxacin in patients with pulmonary tuberculosisF A Sirgel, F J Botha, D P Parkin, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1993
The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts: a new method of drug assessmentF A Sirgel, F J Botha, D P Parkin, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 2, 2002
The early bactericidal activity of streptomycinP R Donald, F A Sirgel, A Venter, et al.
Archives of Disease in Childhood|May 24, 2005
Isoniazid pharmacokinetics in children treated for respiratory tuberculosisH S Schaaf, D P Parkin, H I Seifart, et al.
Expert Review of Anti-Infective Therapy|October 16, 2004
Early bactericidal activity of antituberculosis agentsP R Donald, F A Sirgel, A Venter, et al.
Scandinavian Journal of Infectious Diseases|July 14, 2001
Early bactericidal activity of amoxicillin in combination with clavulanic acid in patients with sputum smear-positive pulmonary tuberculosisP R Donald, F A Sirgel, A Venter, et al.
European Journal of Clinical Pharmacology|May 17, 2007
The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazidP R Donald, D P Parkin, H I Seifart, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2004
The influence of human N-acetyltransferase genotype on the early bactericidal activity of isoniazidP R Donald, F A Sirgel, A Venter, et al.
American Journal of Respiratory and Critical Care Medicine|October 6, 1997
The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosisP R Donald, F A Sirgel, F J Botha, et al.
Pageof 4